Your browser doesn't support javascript.
loading
Hydroxyapatite nanoparticles drive the potency of Toll-like receptor 9 agonist for amplified innate and adaptive immune response.
Zeng, Qin; Wang, Ruiqi; Hua, Yuchen; Wu, Hongfeng; Chen, Xuening; Xiao, You-Cai; Ao, Qiang; Zhu, Xiangdong; Zhang, Xingdong.
Affiliation
  • Zeng Q; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064 China.
  • Wang R; NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterials & Institute of Regulatory Science for Medical Devices & NMPA Research Base of Regulatory Science for Medical Devices, Sichuan University, Chengdu, 610064 China.
  • Hua Y; College of Biomedical Engineering, Sichuan University, Chengdu, 610064 China.
  • Wu H; Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan University, Chengdu, 610041 China.
  • Chen X; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064 China.
  • Xiao YC; College of Biomedical Engineering, Sichuan University, Chengdu, 610064 China.
  • Ao Q; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064 China.
  • Zhu X; College of Biomedical Engineering, Sichuan University, Chengdu, 610064 China.
  • Zhang X; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064 China.
Nano Res ; 15(10): 9286-9297, 2022.
Article in En | MEDLINE | ID: mdl-35911480
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Nano Res Year: 2022 Document type: Article Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Nano Res Year: 2022 Document type: Article Country of publication: China